LEADER 04441nam 2200625Ia 450 001 9910139773303321 005 20170814175146.0 010 $a1-282-34956-2 010 $a9786612349560 010 $a0-470-74780-3 010 $a0-470-74779-X 035 $a(CKB)1000000000799299 035 $a(EBL)470228 035 $a(OCoLC)466336957 035 $a(SSID)ssj0000303940 035 $a(PQKBManifestationID)11226784 035 $a(PQKBTitleCode)TC0000303940 035 $a(PQKBWorkID)10277337 035 $a(PQKB)10130159 035 $a(MiAaPQ)EBC470228 035 $a(PPN)243308159 035 $a(EXLCZ)991000000000799299 100 $a20090623d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNanotoxicity$b[electronic resource] $ein vivo and in vitro models to health risks /$feditors, Saura C. Sahu and Daniel Casciano 210 $aChichester, West Sussex ;$aHoboken, NJ $cJohn Wiley & Sons$d2009 215 $a1 online resource (636 p.) 300 $aDescription based upon print version of record. 311 $a0-470-74137-6 320 $aIncludes bibliographical references and index. 327 $aNanotoxicity; Contents; Preface; List of Contributors; Acknowledgments; 1 Characterization of Nanomaterials for Toxicological Evaluation; 2 Criteria and Implementation of Physical and Chemical Characteristics of Nanomaterials for Human Health Effects and Ecological Toxicity Studies; 3 Considerations for the Design of Toxicity Studies of Inhaled Nanomedicines; 4 High Aspect Ratio Nanoparticles and the Fibre Pathogenicity Paradigm; 5 Application of Zinc Oxide Quantum Dots in Food Safety 327 $a6 Evaluation of Nanotoxicity of Foods and Drugs: Biological Properties of Red Elemental Selenium at Nano Size (Nano-Se) In Vitro and In Vivo7 Evaluation of Toxicity of Nanostructures in Biological Systems; 8 Developing Bioassay Methods for Evaluating Pulmonary Hazards from Nanoscale or Fine Quartz/Titanium Dioxide Particulate Materials; 9 Nanoparticles: Is Neurotoxicity a Concern?; 10 Hepatotoxic Potential of Nanomaterials; 11 Nanotoxicity in Blood: Effects of Engineered Nanomaterials on Platelets; 12 Sources, Fate and Effects of Engineered Nanomaterials in the Aquatic Environment 327 $a13 Nanotoxicity of Metal Oxide Nanoparticles in Vivo14 In Vivo Hypersensitive Pulmonary Disease Models for Nanotoxicity; 15 In Vivo and In Vitro Models for Nanotoxicology Testing; 16 In Vitro and In Vivo Toxicity Study of Nanoparticles; 17 In Vitro and In Vivo Models for Nanotoxicity Testing; 18 In Vitro Models for Nanotoxicity Testing; 19 In Vitro Human Lung Cell Culture Models to Study the Toxic Potential of Nanoparticles; 20 Iron Oxide Magnetic Nanoparticle Nanotoxicity: Incidence and Mechanisms; 21 Toxicity Testing and Evaluation of Nanoparticles: Challenges in Risk Assessment 327 $a22 Evaluating Strategies For Risk Assessment of Nanomaterials23 Strategies for Risk Assessment of Nanomaterials; 24 Metal Nanoparticle Health Risk Assessment; 25 Application of Toxicology Studies in Assessing the Health Risks of Nanomaterials in Consumer Products; 26 Safety Assessment of Engineered Nanomaterials in Direct Food Additives and Food Contact Materials; Index; Color Plate 330 $aNanomaterials - substances smaller than 100 nanometers in size - have been added in recent years to an increasing numbers of consumer products used in day-to-day life; in food packaging, medical devices, pharmaceuticals, cosmetics, odor-resistant textiles and household appliances. The extensive application of nanomaterials in a wide range of products for human use poses a potential for toxicity risk to human health and the environment. Such adverse effects of nanomaterials on human health have triggered the development of a new scientific discipline known as "nanotoxicity" - the study of the t 606 $aNanostructured materials$xToxicology 606 $aToxicity testing 615 0$aNanostructured materials$xToxicology. 615 0$aToxicity testing. 676 $a338.4/76205 676 $a338.476205 676 $a615.902 701 $aSahu$b Saura C$0860594 701 $aCasciano$b Daniel A$0882839 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910139773303321 996 $aNanotoxicity$91972242 997 $aUNINA